ATE476959T1 - Pharmazeutische und kosmetische zubereitungen - Google Patents
Pharmazeutische und kosmetische zubereitungenInfo
- Publication number
- ATE476959T1 ATE476959T1 AT03809723T AT03809723T ATE476959T1 AT E476959 T1 ATE476959 T1 AT E476959T1 AT 03809723 T AT03809723 T AT 03809723T AT 03809723 T AT03809723 T AT 03809723T AT E476959 T1 ATE476959 T1 AT E476959T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical
- cosmetic preparations
- silicon dioxide
- cosmetic formulations
- highly disperse
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10250711A DE10250711A1 (de) | 2002-10-31 | 2002-10-31 | Pharmazeutische und kosmetische Zubereitungen |
PCT/EP2003/011054 WO2004039349A1 (en) | 2002-10-31 | 2003-10-07 | Pharmaceutical and cosmetic formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE476959T1 true ATE476959T1 (de) | 2010-08-15 |
Family
ID=32115006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03809723T ATE476959T1 (de) | 2002-10-31 | 2003-10-07 | Pharmazeutische und kosmetische zubereitungen |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060292192A1 (de) |
EP (1) | EP1558212B1 (de) |
JP (1) | JP2006506388A (de) |
KR (1) | KR100755193B1 (de) |
CN (1) | CN100488565C (de) |
AT (1) | ATE476959T1 (de) |
AU (1) | AU2003276059A1 (de) |
DE (2) | DE10250711A1 (de) |
ES (1) | ES2350742T3 (de) |
WO (1) | WO2004039349A1 (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
DE10320196A1 (de) * | 2002-12-20 | 2004-07-08 | Henkel Kg Auf Aktien | Bleichmittelhaltige Wasch- oder Reinigungsmittel |
JP2007509036A (ja) * | 2003-05-23 | 2007-04-12 | デグサ アクチエンゲゼルシャフト | 過酸化水素及び疎水化二酸化ケイ素を含有する粉体状混合物 |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
WO2005058256A1 (de) * | 2003-12-01 | 2005-06-30 | Degussa Ag | Verstreichbare kosmetische zubereitung mit hohem wassergehalt |
DE102004031785A1 (de) * | 2004-07-01 | 2006-01-26 | Degussa Ag | Polyol enthaltende Siliciumdioxid-Dispersion |
DE102004037045A1 (de) | 2004-07-29 | 2006-04-27 | Degussa Ag | Wässrige Silan-Nanokomposite |
DE102004037044A1 (de) | 2004-07-29 | 2006-03-23 | Degussa Ag | Mittel zur Ausstattung von auf Cellulose und/oder Stärke basierenden Substraten mit Wasser abweisenden und gleichzeitig pilz-, bakterien-, insekten- sowie algenwidrigen Eigenschaften |
JP4834553B2 (ja) * | 2004-09-17 | 2011-12-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
DE102004049427A1 (de) | 2004-10-08 | 2006-04-13 | Degussa Ag | Polyetherfunktionelle Siloxane, polyethersiloxanhaltige Zusammensetzungen, Verfahren zu deren Herstellung und deren Verwendung |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
DE102004056862A1 (de) * | 2004-11-25 | 2006-06-14 | Degussa Ag | Pulverförmige, kosmetische Zubereitung mit hohem Wassergehalt |
DE102005055226A1 (de) * | 2004-12-24 | 2006-07-13 | Degussa Ag | Lagerung pulverförmiger Stoffe mit hohem Wassergehalt |
DE102005004872A1 (de) | 2005-02-03 | 2006-08-10 | Degussa Ag | Wässrige Emulsionen von funktionellen Alkoxysilanen und deren kondensierten Oligomeren, deren Herstellung und Verwendung zur Oberflächenbehandlung |
DE102005032427A1 (de) * | 2005-07-12 | 2007-01-18 | Degussa Ag | Aluminiumoxid-Dispersion |
JP4989476B2 (ja) * | 2005-08-02 | 2012-08-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 血管新生阻害物質の効果を検定する方法 |
DE102006006655A1 (de) * | 2005-08-26 | 2007-03-01 | Degussa Ag | Cellulose- bzw. lignocellulosehaltige Verbundwerkstoffe auf der Basis eines auf Silan basierenden Komposits als Bindemittel |
DE102006006656A1 (de) | 2005-08-26 | 2007-03-01 | Degussa Ag | Silan enthaltendes Bindemittel für Verbundwerkstoffe |
JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
DK1924246T3 (en) | 2005-09-15 | 2016-01-18 | Genzyme Corp | PORTION LETTER DEFINITION OF amine polymers |
DE102005053071A1 (de) | 2005-11-04 | 2007-05-16 | Degussa | Verfahren zur Herstellung von ultrafeinen Pulvern auf Basis Polymaiden, ultrafeinen Polyamidpulver sowie deren Verwendung |
CA2627598C (en) | 2005-11-07 | 2013-06-25 | Eisai R & D Management Co., Ltd. | Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
EP1813573A1 (de) * | 2006-01-25 | 2007-08-01 | Degussa GmbH | Verfahren zur Herstellung von Gummimischungen |
DE102006017701A1 (de) * | 2006-04-15 | 2007-10-25 | Degussa Gmbh | Silicium-Titan-Mischoxidpulver, Dispersion hiervon und daraus hergestellter titanhaltiger Zeolith |
DK2026880T3 (en) * | 2006-05-05 | 2018-10-01 | Blaa Lonid Hf | PHARMACEUTICAL AND COSMETIC APPLICATION OF SILICA |
JP2009536165A (ja) * | 2006-05-10 | 2009-10-08 | エボニック デグサ ゲーエムベーハー | 医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用 |
EP2023898A1 (de) | 2006-05-10 | 2009-02-18 | Evonik Degussa GmbH | Verwendung von rollen-kompaktiertem pyrogen hergestelltem siliziumdioxid in pharmazeutischen zusammensetzungen |
JP5190361B2 (ja) | 2006-05-18 | 2013-04-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 甲状腺癌に対する抗腫瘍剤 |
TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
US8155674B2 (en) * | 2006-08-22 | 2012-04-10 | Research In Motion Limited | Apparatus, and associated method, for dynamically configuring a page message used to page an access terminal in a radio communication system |
DE102006039269A1 (de) * | 2006-08-22 | 2008-02-28 | Evonik Degussa Gmbh | Dispersion von Aluminiumoxid, Beschichtungszusammensetzung und tintenaufnehmendes Medium |
EP2066293A2 (de) | 2006-09-29 | 2009-06-10 | Genzyme Corporation | Amid-dendrimer-zusammensetzungen |
BRPI0720234A2 (pt) | 2006-12-14 | 2013-12-24 | Genzyme Corp | Composição farmacêutica |
AU2008211952B2 (en) | 2007-01-29 | 2012-07-19 | Eisai R & D Management Co., Ltd. | Composition for treatment of undifferentiated-type of gastric cancer |
ES2601820T3 (es) | 2007-02-23 | 2017-02-16 | Gilead Sciences, Inc. | Moduladores de propiedades terapéutica de las farmacocinéticas |
EP1982964B1 (de) | 2007-04-20 | 2019-02-27 | Evonik Degussa GmbH | Organosiliciumverbindung enthaltende Mischung und deren Verwendung |
DE102007038314A1 (de) | 2007-08-14 | 2009-04-16 | Evonik Degussa Gmbh | Verfahren zur kontrollierten Hydrolyse und Kondensation von Epoxy-funktionellen Organosilanen sowie deren Condensation mit weiteren organofunktionellen Alkoxysilanen |
DE102007040246A1 (de) * | 2007-08-25 | 2009-02-26 | Evonik Degussa Gmbh | Strahlenhärtbare Formulierungen |
DE102008007261A1 (de) | 2007-08-28 | 2009-03-05 | Evonik Degussa Gmbh | Wässrige Silansysteme basierend auf Bis(trialkoxysilyalkyl)aminen |
DE102007049743A1 (de) * | 2007-10-16 | 2009-04-23 | Evonik Degussa Gmbh | Silicium-Titan-Mischoxidpulver, Dispersion hiervon und daraus hergestellter titanhaltiger Zeolith |
KR101513326B1 (ko) * | 2007-11-09 | 2015-04-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 혈관 신생 저해 물질과 항종양성 백금 착물의 병용 |
CN102083467B (zh) | 2008-03-11 | 2013-12-25 | Aska制药株式会社 | 固体分散体及其药物组合物、以及它们的制备方法 |
SI2296633T1 (sl) * | 2008-05-02 | 2015-11-30 | Gilead Sciences, Inc. | Uporaba trdnih nosilnih delcev za izboljšanje predelovalnih sposobnosti farmacevtskega sredstva |
DE102009002477A1 (de) | 2009-04-20 | 2010-10-21 | Evonik Degussa Gmbh | Quartäre-aminofunktionelle, siliciumorganische Verbindungen enthaltende Zusammensetzung sowie deren Herstellung und Verwendung |
DE102009002499A1 (de) | 2009-04-20 | 2010-10-21 | Evonik Degussa Gmbh | Dispersion enthaltend mit quartären, aminofunktionellen siliciumorganischen Verbindungen oberflächenmodifizierte Siliciumdioxidpartikel |
CN102892411B (zh) * | 2009-12-18 | 2015-01-21 | 恩多提斯药业公司 | 含有合成的低聚糖的药物口服剂型 |
US8906949B2 (en) * | 2010-05-21 | 2014-12-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of zolmitriptan and process for preparing the same |
CA2802644C (en) | 2010-06-25 | 2017-02-21 | Eisai R & D Management Co., Ltd. | Antitumor agent using compounds having kinase inhibitory effect in combination |
CA2828946C (en) | 2011-04-18 | 2016-06-21 | Eisai R&D Management Co., Ltd. | Therapeutic agent for tumor |
US9945862B2 (en) | 2011-06-03 | 2018-04-17 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
US9549894B2 (en) * | 2012-06-21 | 2017-01-24 | L'oreal | Water-releasing cosmetic composition including a hydrophobic silica |
WO2014098176A1 (ja) | 2012-12-21 | 2014-06-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | キノリン誘導体のアモルファス及びその製造方法 |
KR102204279B1 (ko) | 2013-05-14 | 2021-01-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 자궁내막암 대상의 렌바티닙 화합물에 대한 반응성을 예측 및 평가하기 위한 생체표지 |
MX2017001980A (es) | 2014-08-28 | 2017-05-04 | Eisai R&D Man Co Ltd | Derivado de quinolina muy puro y metodo para su produccion. |
BR112017017428A2 (pt) | 2015-02-25 | 2018-04-03 | Eisai R&D Management Co., Ltd. | ?método para supressão do amargor de derivado de quinolina? |
KR102662228B1 (ko) | 2015-03-04 | 2024-05-02 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합 |
JP6757959B2 (ja) | 2015-06-16 | 2020-09-23 | 株式会社 PRISM BioLab | 抗がん剤 |
AU2019213007B2 (en) * | 2018-01-29 | 2024-04-04 | Pathelen Health Care Ag | Hydrophilic/hydrophobic pharmaceutical composition and method of its production and use |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4034077A (en) * | 1973-01-02 | 1977-07-05 | E. R. Squibb & Sons, Inc. | Ointments and powders containing sebacic acid |
US4590062A (en) * | 1984-04-16 | 1986-05-20 | Tech Trade Corp. | Dry direct compression compositions for controlled release dosage forms |
US6193795B1 (en) * | 1993-08-02 | 2001-02-27 | Degussa Corporation | Low structure pyrogenic hydrophilic and hydrophobic metallic oxides, production and use |
US6471994B1 (en) * | 1995-01-09 | 2002-10-29 | Edward Mendell Co., Inc. | Pharmaceutical excipient having improved compressibility |
US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
PT725037E (pt) * | 1995-02-04 | 2001-07-31 | Degussa | Granulados a base de dioxido de silicio preparado pirogenicamente processo para a sua preparacao e sua utilizacao |
FR2781162B1 (fr) * | 1998-07-17 | 2000-11-17 | Andre Mazaury | Procede de traitement cosmetique de la peau, du cuir chevelu et de leurs derives utilisant des ondes electro-magnetiques et des huiles essentielles |
JP4352592B2 (ja) * | 2000-07-11 | 2009-10-28 | コニカミノルタホールディングス株式会社 | セルロースエステルドープ組成物、セルロースエステルフィルムの製造方法、セルロースエステルフィルム及びそれを用いた偏光板 |
EP1172095B1 (de) * | 2000-07-13 | 2002-10-02 | L'oreal | Kosmetisches Reinigungsmittel |
KR20020039976A (ko) * | 2000-11-23 | 2002-05-30 | 조충환 | 펑크 대비용 공기입 타이어 |
DE10126163A1 (de) * | 2001-05-30 | 2002-12-05 | Degussa | Pharmazeutische Zubereitungen |
FR2827515B1 (fr) * | 2001-07-20 | 2005-06-03 | Oreal | Composition moussante a base de silice et de polymere cationique |
US6951642B2 (en) * | 2001-09-28 | 2005-10-04 | 3M Innovative Properties Company | Water-in-oil emulsions with anionic groups, compositions, and methods |
-
2002
- 2002-10-31 DE DE10250711A patent/DE10250711A1/de not_active Ceased
-
2003
- 2003-10-07 AU AU2003276059A patent/AU2003276059A1/en not_active Abandoned
- 2003-10-07 DE DE60333776T patent/DE60333776D1/de not_active Expired - Lifetime
- 2003-10-07 WO PCT/EP2003/011054 patent/WO2004039349A1/en active Application Filing
- 2003-10-07 EP EP03809723A patent/EP1558212B1/de not_active Expired - Lifetime
- 2003-10-07 ES ES03809723T patent/ES2350742T3/es not_active Expired - Lifetime
- 2003-10-07 JP JP2004547507A patent/JP2006506388A/ja active Pending
- 2003-10-07 AT AT03809723T patent/ATE476959T1/de not_active IP Right Cessation
- 2003-10-07 KR KR1020057007314A patent/KR100755193B1/ko not_active IP Right Cessation
- 2003-10-07 CN CNB2003801024200A patent/CN100488565C/zh not_active Expired - Fee Related
- 2003-10-07 US US10/530,326 patent/US20060292192A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2350742T3 (es) | 2011-01-26 |
WO2004039349A1 (en) | 2004-05-13 |
CN100488565C (zh) | 2009-05-20 |
KR20050071632A (ko) | 2005-07-07 |
DE10250711A1 (de) | 2004-05-19 |
US20060292192A1 (en) | 2006-12-28 |
DE60333776D1 (de) | 2010-09-23 |
EP1558212A1 (de) | 2005-08-03 |
CN1708287A (zh) | 2005-12-14 |
EP1558212B1 (de) | 2010-08-11 |
KR100755193B1 (ko) | 2007-09-05 |
AU2003276059A1 (en) | 2004-05-25 |
WO2004039349A8 (en) | 2004-06-24 |
JP2006506388A (ja) | 2006-02-23 |
AU2003276059A8 (en) | 2004-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60333776D1 (de) | Pharmazeutische und kosmetische zubereitungen | |
DE59912910D1 (de) | Verwendung von Nanodispersionen in pharmazeutischen Endformulierungen | |
ATE243516T1 (de) | Amoxicillin und clavulanat enthaltende arzneizubereitungen | |
BR0211769A (pt) | Combinações antineoplásicas | |
ATE286057T1 (de) | Pharmazeutische zubereitungen enthaltend clavulansäure | |
DK1264602T3 (da) | Farmaceutiske præparater | |
DE60224284D1 (de) | Stabile formulierung von modifiziertem glp-1 | |
PA8539901A1 (es) | Novedosa sal de succinato de o-desmetil-venlafaxina | |
ATE282428T1 (de) | Pharmazeutische dosierungsform von amorphem nilfenavir mesylat | |
DE50105387D1 (de) | Elektrolythaltige kosmetische, pharmazeutische und dermatologische mittel | |
ATA13842001A (de) | Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung | |
HK1075616A1 (en) | Pharmaceutical formulation comprising melatonin | |
DE50213084D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
TR200103819T2 (tr) | kanser tedavisinde ET743 terkipleri ve kullanımları | |
PT1237551E (pt) | Formulacoes farmaceuticas contendo zolmitriptano | |
ATE383868T1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
DE60116359D1 (de) | Kahalalid f formulierung | |
DE50212687D1 (de) | Kosmetische und/oder pharmazeutische emulsionen | |
ATE301999T1 (de) | Racecadotril enthaltende trockene pulverformulierung | |
DE50014257D1 (de) | Kosmetische Zubereitungen enthaltend molekulare Addukte aus Biotin und/oder Biotinestern und Cyclodextrinen | |
ATE405293T1 (de) | Selbstemulgierende und selbstmicroemulgierende formulierungen zur oralen verabreichung von taxoiden | |
DE59812317D1 (de) | "Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron" | |
ATA90422002A (de) | Neues hydroxyliertes 3-phenoxy-3-phenyl-1- aminopropan und dieses aminopropan enthaltende pharmazeutische formulierung | |
DE60106266D1 (de) | Bioverfügbare darreichungsform von loratadin | |
DE50011647D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |